Search Tag: cardiovascular disease

Executive Health Management

Call to Action for the Cardiovascular Segment of COVID-19

2020 11 May

The rapid global distribution of the Coronavirus and the fear of collapsing healthcare systems have forced hospitals to concentrate on the treatment of COVID-19 patients and allocate their resources accordingly. As a consequence up to 80% of the elective cardiovascular (CV) interventions have been indefinitely postponed.1 This measure resulted in a... Read more

Executive Health Management

Global COVID-19 Pandemic - Compelling Effects on Cardiovascular Medicine

2020 11 May

Summary: Quarantining and public interventions during the COVID-19 pandemic have raised concerns about a decrease in presentations for urgent and life-threatening cardiovascular diseases. Cardiovascular disease may remain undiagnosed for a longer duration. How can this be addressed? Introduction All members of the coronaviruses (CoV)... Read more

Executive Health Management

Bright Ideas

2020 09 Mar

HealthManagement.org rounds up exciting developments that have all the marks of healthcare game changers. What do you think? Advancements in Cardiac Imaging Conventional imaging still remains important for the assessment of cardiac structure and function. However, advanced echocardiography with strain imaging techniques, tissue characterisation... Read more

Executive Health Management

The Future of Cardiovascular Medicine – Technology, Gender Bias and Treatment Strategies

2019 13 Nov

Prof. Mamas A Mamas is a structural interventional cardiologist, treating patients with underlying coronary artery with percutaneous coronary intervention (PCI) in both the elective and emergency setting and undertaking Transcatheter Aortic Valve Interventions (TAVI). He is also the Associate Editor of Circulation Cardiovascular Interventions... Read more

Executive Health Management

Cash Cow Infographic

2019 13 Nov

An overview of healthcare industry revenue, growth and expenditures.  Read more

Executive Health Management

The Sex and Gender Influence on Hypertension

2019 02 Oct

Despite underlying physiological differences and a different set of risk factors, diagnosis, management, and treatment strategies for hypertension do not account for sex and gender variances. Evidence-based guidelines for hypertension treatment from clinical trials are similar between males and females; however, most of these trials do not... Read more

Executive Health Management

The Future of Cardiovascular Disease Treatment and Management

2019 26 Aug

Arthur M. Feldman, MD, PhD, Laura H. Carnell Professor of Medicine at the Lewis Katz School of Medicine at Temple University, has been recognised with the 2019 Distinguished Scientist Award-Basic Domain by the American College of Cardiology. Prof. Feldman has received this honour due to his contribution towards improving cardiovascular health and... Read more

Executive Health Management

Cardiology and mHealth – Rethink About Monitoring

2019 26 Aug

Summary: Overview about the value of mHealth in cardiology exemplified by some promising tools that for sure will change the way cardiology is practiced, especially in the management of rhythm disturbances like atrial fibrillation.   Where Are We Now?   Nowadays, there is a lot of hype about the role of wearables and mobile health (mHealth)... Read more

Executive Health Management

Sex & Gender Impacts in Cardiovascular Disease: A “Typical” Presentation of Cardiovascular Disease?

2019 26 Aug

Summary: Differences in sex and gender may account for gaps in treatment and prevention of cardiovascular disease, but at the same time, it also gives the opportunity for personalised sex and gender-specific medicine.   Typical presentations in medicine are defined in ways that health care professionals can draw on past experiences and education... Read more

Executive Health Management

Hypertension – Prevention is Better Than Cure

2019 26 Aug

How can we get the most common, costly, and modifiable cardiovascular risk factor under control?     Cardiovascular disease (CVD) is the number one cause of death with an upward trend beyond 30% and a tripling in costs between 2010 and 2030, placing a significant economic burden on public healthcare services. 1,2,3 The most common risk factor... Read more